标题/作者	年份
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017 PS Sullivan, RM Giler, F Mouhanna, ES Pembleton, JL Guest, J Jones, ... Annals of epidemiology 28 (12), 833-840	2018
Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review KH Mayer, A Agwu, D Malebranche Advances in Therapy 37, 1778-1811	2020
“A gay man and a doctor are just like, a recipe for destruction”: How racism and homonegativity in healthcare settings influence PrEP uptake among young Black MSM K Quinn, J Dickson-Gomez, M Zarwell, B Pearson, M Lewis AIDS and Behavior 23, 1951-1963	2019
Implementation strategies to increase PrEP uptake in the South PS Sullivan, L Mena, L Elopre, AJ Siegler Current HIV/AIDS Reports 16, 259-269	2019
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses PS Sullivan, AS Johnson, ES Pembleton, R Stephenson, AC Justice, ... The Lancet 397 (10279), 1095-1106	2021
HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood SK Calabrese, JF Dovidio, M Tekeste, T Taggart, RW Galvao, CB Safon, ... Journal of acquired immune deficiency syndromes (1999) 79 (1), 46	2018
Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017 KC Coy, RJ Hazen, HS Kirkham, A Delpino, AJ Siegler Journal of the International AIDS Society 22 (2), e25252	2019
Differences in medical mistrust between black and white women: implications for patient–provider communication about PrEP M Tekeste, S Hull, JF Dovidio, CB Safon, O Blackstock, T Taggart, ... AIDS and Behavior 23, 1737-1748	2019
National trends in HIV pre‐exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017 PS Sullivan, TH Sanchez, M Zlotorzynska, CJ Chandler, RC Sineath, ... Journal of the International AIDS Society 23 (3), e25461	2020
Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States AJ Siegler, A Bratcher, KM Weiss American journal of public health 109 (9), 1216-1223	2019
Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study DP Serota, ES Rosenberg, PS Sullivan, AL Thorne, CPM Rolle, C Del Rio, ... Clinical infectious diseases 71 (3), 574-582	2020
Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP SK Calabrese, TC Willie, RW Galvao, M Tekeste, JF Dovidio, CB Safon, ... Journal of acquired immune deficiency syndromes (1999) 81 (4), 395	2019
Considering stigma in the provision of HIV pre-exposure prophylaxis: Reflections from current prescribers SK Calabrese, M Tekeste, KH Mayer, M Magnus, DS Krakower, ... AIDS patient care and STDs 33 (2), 79-88	2019
Pre-exposure prophylaxis for HIV prevention in women: current status and future directions I Hodges-Mameletzis, VA Fonner, S Dalal, N Mugo, B Msimanga-Radebe, ... Drugs 79, 1263-1276	2019
Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation PS Sullivan, AJ Siegler Sexual health 15 (6), 522-527	2018
Global implementation of PrEP for HIV prevention: setting expectations for impact MN Pyra, JE Haberer, N Hasen, J Reed, NR Mugo, JM Baeten Journal of the International AIDS Society 22 (8), e25370	2019
A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource PS Sullivan, C Woodyatt, C Koski, E Pembleton, P McGuinness, J Taussig, ... Journal of medical Internet research 22 (10), e23173	2020
Policy-and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018 AJ Siegler, CC Mehta, F Mouhanna, RM Giler, A Castel, E Pembleton, ... Annals of Epidemiology 45, 24-31. e3	2020
Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics HM Scott, M Spinelli, E Vittinghoff, A Morehead-Gee, A Hirozawa, ... Aids 33 (14), 2189-2195	2019
Current and future PrEP medications and modalities: on-demand, injectables, and topicals MR Beymer, IW Holloway, C Pulsipher, RJ Landovitz Current hiv/aids Reports 16, 349-358	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。